BRCA1-associated breast cancers differ from tumours not associated with BRCA mutations with respect to pathological features, e.g. they are more often estrogen receptor negative and high grade and have a higher frequency of somatic abnormalities in prognostically important genes such as P53 [2,3]. The gene discussed is BRCA1; the disease is breast cancer.